Numerous pathways such as the transforming growth factor-β (TGF-β) and fibroblast growth factor-23 (FGF-23) are part of the complex pathophysiology of atherosclerosis condition, kidney fibrosis and ischemic nephropathy. Here, FGF23 is linked to atherosclerosis.